Cargando…

Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients()

Delays in starting potentially curative treatment for locally-advanced cervical cancer (LACC) decrease survival. Reasons for these delays are poorly understood. We conducted a retrospective chart review examining disparities in time from diagnosis of LACC to first clinic visit and to initiation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Saris, Daniel H., Pena, Daniella, Haggerty, Ashley F., Taunk, Neil K., Ko, Emily M., Smith, Anna Jo Bodurtha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311198/
https://www.ncbi.nlm.nih.gov/pubmed/37397239
http://dx.doi.org/10.1016/j.gore.2023.101177
_version_ 1785066691260055552
author Saris, Daniel H.
Pena, Daniella
Haggerty, Ashley F.
Taunk, Neil K.
Ko, Emily M.
Smith, Anna Jo Bodurtha
author_facet Saris, Daniel H.
Pena, Daniella
Haggerty, Ashley F.
Taunk, Neil K.
Ko, Emily M.
Smith, Anna Jo Bodurtha
author_sort Saris, Daniel H.
collection PubMed
description Delays in starting potentially curative treatment for locally-advanced cervical cancer (LACC) decrease survival. Reasons for these delays are poorly understood. We conducted a retrospective chart review examining disparities in time from diagnosis of LACC to first clinic visit and to initiation of treatment based on insurance status within a single health system. We analyzed time to treatment using multivariate regression, adjusted for race, age, and insurance status. 25% of patients had Medicaid and 53% had private insurance. Having Medicaid was associated with delayed time from diagnosis to seeing a radiation oncologist (Mean 76.9 v. 31.3 days, p = 0.03). However, time from first radiation oncology visit to starting radiation was not delayed (Mean 22.6 v. 22.2 days, p = 0.67). Patients with locally-advanced cervical cancer and Medicaid had over double the time from pathologic diagnosis of cervical cancer to seeing radiation oncology; insurance disparities were not observed in treatment start after seeing radiation oncology. Improved referral and navigation processes for patients with Medicaid are needed to improve timely receipt of radiation and potentially improve survival.
format Online
Article
Text
id pubmed-10311198
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103111982023-07-01 Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients() Saris, Daniel H. Pena, Daniella Haggerty, Ashley F. Taunk, Neil K. Ko, Emily M. Smith, Anna Jo Bodurtha Gynecol Oncol Rep Short Communication Delays in starting potentially curative treatment for locally-advanced cervical cancer (LACC) decrease survival. Reasons for these delays are poorly understood. We conducted a retrospective chart review examining disparities in time from diagnosis of LACC to first clinic visit and to initiation of treatment based on insurance status within a single health system. We analyzed time to treatment using multivariate regression, adjusted for race, age, and insurance status. 25% of patients had Medicaid and 53% had private insurance. Having Medicaid was associated with delayed time from diagnosis to seeing a radiation oncologist (Mean 76.9 v. 31.3 days, p = 0.03). However, time from first radiation oncology visit to starting radiation was not delayed (Mean 22.6 v. 22.2 days, p = 0.67). Patients with locally-advanced cervical cancer and Medicaid had over double the time from pathologic diagnosis of cervical cancer to seeing radiation oncology; insurance disparities were not observed in treatment start after seeing radiation oncology. Improved referral and navigation processes for patients with Medicaid are needed to improve timely receipt of radiation and potentially improve survival. Elsevier 2023-04-03 /pmc/articles/PMC10311198/ /pubmed/37397239 http://dx.doi.org/10.1016/j.gore.2023.101177 Text en © 2023 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Short Communication
Saris, Daniel H.
Pena, Daniella
Haggerty, Ashley F.
Taunk, Neil K.
Ko, Emily M.
Smith, Anna Jo Bodurtha
Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients()
title Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients()
title_full Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients()
title_fullStr Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients()
title_full_unstemmed Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients()
title_short Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients()
title_sort insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients()
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311198/
https://www.ncbi.nlm.nih.gov/pubmed/37397239
http://dx.doi.org/10.1016/j.gore.2023.101177
work_keys_str_mv AT sarisdanielh insurancestatusandtimetoradiationcareafterpathologicdiagnosisforcervicalcancerpatients
AT penadaniella insurancestatusandtimetoradiationcareafterpathologicdiagnosisforcervicalcancerpatients
AT haggertyashleyf insurancestatusandtimetoradiationcareafterpathologicdiagnosisforcervicalcancerpatients
AT taunkneilk insurancestatusandtimetoradiationcareafterpathologicdiagnosisforcervicalcancerpatients
AT koemilym insurancestatusandtimetoradiationcareafterpathologicdiagnosisforcervicalcancerpatients
AT smithannajobodurtha insurancestatusandtimetoradiationcareafterpathologicdiagnosisforcervicalcancerpatients